Ciglitazone increases basal cytokine expression in the central nervous system of adult rats

Brain Research

Volumn 1034, Issue 1-2, 2005, Pages 139-146

  Gélinas, David S ^a,b   Lambermon, Mark H L ^a   McLaurin, JoAnne ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Interleukin 1beta; Interleukin 4; Perosixome proliferator activated receptor; Thiazolidinediones; Tumor necrosis factor alpha

Indexed keywords

CIGLITAZONE; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN;

EID: 13844274912     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.12.003     Document Type: Article

References (38)

1. A. Chawla, Y. Barak, L. Nagy, D. Liao, P. Tontonoz, and R.M. Evans PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation Nat. Med. 7 2001 48 52
2. S.W. Chung, B.Y. Kang, and T.S. Kim Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: involvement of physical association between PPAR-gamma and the nuclear factor of activated T cells transcription factor Mol. Pharmacol. 64 2003 1169 1179
3. R.B. Clark, D. Bishop-Bailey, T. Estrada-Hernandez, T. Hla, L. Puddington, and S.J. Padula The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses J. Immunol. 164 2000 1364 1371
4. C.K. Combs, D.E. Johnson, J.C. Karlo, S.B. Cannady, and G.E. Landreth Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists J. Neurosci. 20 2000 558 567
5. C.K. Combs, P. Bates, J.C. Karlo, and G.E. Landreth Regulation of beta-amyloid stimulated proinflammatory responses by peroxisome proliferator-activated receptor alpha Neurochem. Int. 39 2001 449 457
6. T.E. Cullingford, K. Bhakoo, S. Peuchen, C.T. Dolphin, R. Patel, and J.B. Clark Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system J. Neurochem. 70 1998 1366 1375
7. S. Cuzzocrea, B. Pisano, L. Dugo, A. Ianaro, D. Britti, N.S. Patel, R.D. Paola, T. Genovese, M.D. Rosa, A.P. Caputi, and C. Thiemermann Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein Intensive Care Med. 30 2004 951 956
8. S. Cuzzocrea, B. Pisano, L. Dugo, A. Ianaro, P. Maffia, N.S. Patel, R. Di Paola, A. Ialenti, T. Genovese, P.K. Chatterjee, M. Di Rosa, A.P. Caputi, and C. Thiemermann Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation Eur. J. Pharmacol. 483 2004 79 93
9. R.A. Daynes, and D.C. Jones Emerging roles of PPARs in inflammation and immunity Nat. Rev., Immunol. 2 2002 748 759
10. D.L. Feinstein, E. Galea, V. Gavrilyuk, C.F. Brosnan, C.C. Whitacre, L. Dumitrescu-Ozimek, G.E. Landreth, H.A. Pershadsingh, G. Weinberg, and M.T. Heneka Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis Ann. Neurol. 51 2002 694 702
11. D.S. Gelinas, K. DaSilva, D. Fenili, P. St George-Hyslop, and J. McLaurin Immunotherapy for Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 101 2004 14657 14662
12. M.T. Heneka, T. Klockgether, and D.L. Feinstein Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo J. Neurosci. 20 2000 6862 6867
13. B. Hinz, K. Brune, and A. Pahl 15-Deoxy-Delta(12,14)-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-gamma-independent mechanism Biochem. Biophys. Res. Commun. 302 2003 415 420
14. C. Hofmann, K. Lorenz, S.S. Braithwaite, J.R. Colca, B.J. Palazuk, G.S. Hotamisligil, and B.M. Spiegelman Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance Endocrinology 134 1994 264 270
15. H. Ikeda, S. Taketomi, Y. Sugiyama, Y. Shimura, T. Sohda, K. Meguro, and T. Fujita Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals Arzneimittelforschung 40 1990 156 162
16. C. Jiang, A.T. Ting, and B. Seed PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86
17. T. Kielian, and P.D. Drew Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation J. Neurosci. Res. 71 2003 315 325
18. T. Lemberger, R. Saladin, M. Vazquez, F. Assimacopoulos, B. Staels, B. Desvergne, W. Wahli, and J. Auwerx Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm J. Biol. Chem. 271 1996 1764 1769
19. P.D. Miles, O.M. Romeo, K. Higo, A. Cohen, K. Rafaat, and J.M. Olefsky TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone Diabetes 46 1997 1678 1683
20. M. Mogi, M. Harada, T. Kondo, H. Narabayashi, P. Riederer, and T. Nagatsu Transforming growth factor-beta 1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease Neurosci. Lett. 193 1995 129 132
21. M. Niino, K. Iwabuchi, S. Kikuchi, M. Ato, T. Morohashi, A. Ogata, K. Tashiro, and K. Onoe Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma J. Neuroimmunol. 116 2001 40 48
22. M. Ohata, H. Suzuki, K. Sakamoto, K. Hashimoto, H. Nakajima, M. Yamauchi, K. Hokkyo, H. Yamada, and G. Toda Pioglitazone prevents acute liver injury induced by ethanol and lipopolysaccharide through the suppression of tumor necrosis factor-alpha, alcohol Clin. Exp. Res. 28 2004 139S 144S
23. A. Okuno, H. Tamemoto, K. Tobe, K. Ueki, Y. Mori, K. Iwamoto, K. Umesono, Y. Akanuma, T. Fujiwara, H. Horikoshi, Y. Yazaki, and T. Kadowaki Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats J. Clin. Invest. 101 1998 1354 1361
24. M.E. Poynter, and R.A. Daynes Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging J. Biol. Chem. 273 1998 32833 32841
25. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82
26. S. Sacco, D. Agnello, M. Sottocorno, G. Lozza, A. Monopoli, P. Villa, and P. Ghezzi Nonsteroidal anti-inflammatory drugs increase tumor necrosis factor production in the periphery but not in the central nervous system in mice and rats J. Neurochem. 71 1998 2063 2070
27. K. Schoonjans, M. Watanabe, H. Suzuki, A. Mahfoudi, G. Krey, W. Wahli, P. Grimaldi, B. Staels, T. Yamamoto, and J. Auwerx Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter J. Biol. Chem. 270 1995 19269 19276
28. K. Schoonjans, J. Peinado-Onsurbe, A.M. Lefebvre, R.A. Heyman, M. Briggs, S. Deeb, B. Staels, and J. Auwerx PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene EMBO J. 15 1996 5336 5348
29. Z. Sfeir, A. Ibrahimi, E. Amri, P. Grimaldi, and N. Abumrad Regulation of FAT/CD36 gene expression: further evidence in support of a role of the protein in fatty acid binding/transport Prostaglandins, Leukot. Essent. Fat. Acids 57 1997 17 21
30. K.K. Tha, Y. Okuma, H. Miyazaki, T. Murayama, T. Uehara, R. Hatakeyama, Y. Hayashi, and Y. Nomura Changes in expressions of proinflammatory cytokines IL-1beta, TNF-alpha and IL-6 in the brain of senescence accelerated mouse (SAM) P8 Brain Res. 885 2000 25 31
31. R. Thieringer, J.E. Fenyk-Melody, C.B. Le Grand, B.A. Shelton, P.A. Detmers, E.P. Somers, L. Carbin, D.E. Moller, S.D. Wright, and J. Berger Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo J. Immunol. 164 2000 1046 1054
32. P. Tontonoz, E. Hu, R.A. Graves, A.I. Budavari, and B.M. Spiegelman mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer Genes Dev. 8 1994 1224 1234
33. P. Tontonoz, E. Hu, J. Devine, E.G. Beale, and B.M. Spiegelman PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene Mol. Cell. Biol. 15 1995 351 357
34. M.P. Vawter, O. Dillon-Carter, W.W. Tourtellotte, P. Carvey, and W.J. Freed TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid Exp. Neurol. 142 1996 313 322
35. J.D. Weaver, M.H. Huang, M. Albert, T. Harris, J.W. Rowe, and T.E. Seeman Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging Neurology 59 2002 371 378
36. T.M. Willson, J.E. Cobb, D.J. Cowan, R.W. Wiethe, I.D. Correa, S.R. Prakash, K.D. Keck, L.B. Moore, S.A. Kliewer, and J.M. Lehmann The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones J. Med. Chem. 39 1996 665 668
37. T.M. Willson, P.J. Brown, D.D. Sternbach, and B.R. Henke The PPARs: from orphan receptors to drug discovery J. Med. Chem. 43 2000 527 550
38. W.H. Yu, L. Go, B.A. Guinn, P.E. Fraser, D. Westaway, and J. McLaurin Phenotypic and functional changes in glial cells as a function of age Neurobiol. Aging 23 2002 105 115